{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:39:41Z","timestamp":1773297581701,"version":"3.50.1"},"reference-count":40,"publisher":"Society of Nuclear Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.2967\/jnumed.108.058602","type":"journal-article","created":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T03:18:18Z","timestamp":1234927098000},"page":"444-453","source":"Crossref","is-referenced-by-count":48,"title":["Pretargeted Versus Directly Targeted Radioimmunotherapy Combined with Anti-CD20 Antibody Consolidation Therapy of Non-Hodgkin Lymphoma"],"prefix":"10.2967","volume":"50","author":[{"given":"Robert M.","family":"Sharkey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habibe","family":"Karacay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Litwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund A.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Hsing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2009,2,17]]},"reference":[{"key":"2021051711584660000_50.3.444.1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210376"},{"key":"2021051711584660000_50.3.444.2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210378"},{"key":"2021051711584660000_50.3.444.3","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e3282efb17c"},{"key":"2021051711584660000_50.3.444.4","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2008.02.009"},{"key":"2021051711584660000_50.3.444.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.5447"},{"key":"2021051711584660000_50.3.444.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.8.2535"},{"key":"2021051711584660000_50.3.444.7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-1004-0009"},{"key":"2021051711584660000_50.3.444.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.8471"},{"key":"2021051711584660000_50.3.444.9","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0037"},{"key":"2021051711584660000_50.3.444.10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.4.1802"},{"key":"2021051711584660000_50.3.444.11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1246"},{"key":"2021051711584660000_50.3.444.12","first-page":"3886S","volume":"9","year":"2003","journal-title":"Clin Cancer Res."},{"key":"2021051711584660000_50.3.444.13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0600982103"},{"key":"2021051711584660000_50.3.444.14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1204"},{"key":"2021051711584660000_50.3.444.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-0890"},{"key":"2021051711584660000_50.3.444.16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0493"},{"key":"2021051711584660000_50.3.444.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2006.05.007"},{"key":"2021051711584660000_50.3.444.18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168146"},{"key":"2021051711584660000_50.3.444.19","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-1004-0008"},{"key":"2021051711584660000_50.3.444.20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-132142"},{"key":"2021051711584660000_50.3.444.21","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0404"},{"key":"2021051711584660000_50.3.444.22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210370"},{"key":"2021051711584660000_50.3.444.23","unstructured":"Morschhauser F, Leonard JP, Fayad L, et al. Humanized anti-CD20 antibody, veltuzumab, in refractory\/recurrent non-Hodgkin's lymphoma: phase I\/II results. J Clin Oncol. In press."},{"key":"2021051711584660000_50.3.444.24","first-page":"77","volume":"44","year":"2003","journal-title":"J Nucl Med."},{"key":"2021051711584660000_50.3.444.25","unstructured":"Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. Rockville, MD: Food and Drug Administration, Center for Drug Evaluation and Research, July 2005. Available at: http:\/\/www.fda.gov\/Cder\/Guidance\/5541fnl.htm. Accessed January 8, 2009."},{"key":"2021051711584660000_50.3.444.26","first-page":"457","volume":"2","year":"1996","journal-title":"Clin Cancer Res."},{"key":"2021051711584660000_50.3.444.27","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1200\/JCO.1999.17.12.3793","volume":"17","year":"1999","journal-title":"J Clin Oncol."},{"key":"2021051711584660000_50.3.444.28","first-page":"21S","volume":"39","year":"1998","journal-title":"J Nucl Med."},{"key":"2021051711584660000_50.3.444.29","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.1996.14.7.1974","volume":"14","year":"1996","journal-title":"J Clin Oncol."},{"key":"2021051711584660000_50.3.444.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199308123290703"},{"key":"2021051711584660000_50.3.444.31","doi-asserted-by":"publisher","DOI":"10.1269\/jrr.47.183"},{"key":"2021051711584660000_50.3.444.32","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.043752"},{"key":"2021051711584660000_50.3.444.33","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0756"},{"key":"2021051711584660000_50.3.444.34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.076"},{"key":"2021051711584660000_50.3.444.35","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh009"},{"key":"2021051711584660000_50.3.444.36","first-page":"637","volume":"52","year":"1992","journal-title":"Cancer Res."},{"key":"2021051711584660000_50.3.444.37","first-page":"3102","volume":"51","year":"1991","journal-title":"Cancer Res."},{"key":"2021051711584660000_50.3.444.38","first-page":"6476","volume":"52","year":"1992","journal-title":"Cancer Res."},{"key":"2021051711584660000_50.3.444.39","first-page":"128S","volume":"46","year":"2005","journal-title":"J Nucl Med."},{"key":"2021051711584660000_50.3.444.40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3284"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.108.058602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T19:11:34Z","timestamp":1621278694000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.108.058602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,17]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,3,2]]},"published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.2967\/jnumed.108.058602"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.108.058602","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,17]]}}}